PREVALENCE AND PREDICTIVE VALUE OF ISLET-CELL ANTIBODIES AND INSULIN AUTOANTIBODIES IN WOMEN WITH GESTATIONAL DIABETES

被引：73

作者：

DAMM, P

KUHL, C

BUSCHARD, K

JAKOBSEN, BK

SVEJGAARD, A

SODOYEZGOFFAUX, F

SHATTOCK, M

BOTTAZZO, GF

MOLSTEDPEDERSEN, L

机构：

[1] Diabetes Centre, Department of Obstetrics and Gynaecology

[2] Tissue Typing Laboratorium, Rigshospitalet, University of Copenhagen

[3] Department of Paediatrics, University of Liege, Liege

[4] Department of Immunology, The London Hospital, London

来源：

DIABETIC MEDICINE | 1994年 / 11卷 / 06期

关键词：

ISLET CELL ANTIBODIES; INSULIN AUTOANTIBODIES; HLA-TYPING; GESTATIONAL DIABETES; DEVELOPMENT OF DIABETES-MELLITUS;

D O I：

10.1111/j.1464-5491.1994.tb02035.x

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

The objective of the present study was to investigate the predictive value of islet cell antibodies (ICA) and insulin autoantibodies (IAA) for development of diabetes in women with previous gestational diabetes (GDM). Two hundred and forty-one previous diet-treated GDM patients and 57 women without previous GDM were examined 2-11 years after the index pregnancy. In subgroups, plasma from the diagnostic OGTT during index pregnancy was analysed for ICA and IAA. Among the previous GDM patients, 3.7 % had developed Type 1 diabetes and 13.7 % Type 2 diabetes. Four (2.9 %) of the 139 GDM patients tested for ICA were ICA-positive and three of these had Type 1 diabetes at follow-up, as well as three ICA-negative patients. The sensitivity, specificity, and predictive value of ICA-positivity for later development of diabetes were 50 %, 99 %, and 75 %, respectively. None of the women was IAA-positive during pregnancy. In conclusion, the majority of the patients with GDM did not show evidence of ongoing autoimmune destruction of the beta cells during the index pregnancy. However, ICA-positive GDM patients had a high risk of developing Type 1 diabetes later in life.

引用

页码：558 / 563

页数：6

共 25 条

[1]

Diabetes, 40, pp. 197-201, (1991)

[2]

Gabbe S, Gestational diabetes mellitus, N Engl J Med, 315, pp. 1025-1026, (1986)

[3]

Guttorm E, Practical screening for diabetes mellitus in pregnant women, Acta Endocrinol, 75, pp. 11-24, (1974)

[4]

O'Sullivan JB, The Boston gestational diabetes studies: review and perspectives, Carbohydrate Metabolism in Pregnancy and the Newborn, pp. 287-294, (1989)

[5]

Bonaficio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Et al., Quantification of islet‐cell antibodies and prediction of insulin‐dependent diabetes, Lancet, 335, pp. 147-149, (1990)

[6]

Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP, Autoimmunity to insulin, beta cell dysfunction and development of insulin dependent diabetes mellitus, Diabete, 35, pp. 139-142, (1985)

[7]

Catalano PM, Tyzbir ED, Sims EAH, Incidence and significance of islet cell antibodies in women with previous gestational diabetes, Diabetes Care, 13, pp. 478-482, (1990)

[8]

Freinkel N, Metzger BE, Phelps RL, Dooley S, Ogata ES, Radvany RM, Et al., Gestational diabetes mellitus: Heterogeneity of maternal age, weight, insulin secretion, HLA antigens and islet cell antibodies and the impact of maternal metabolism on pancreatic B‐cell and somatic development in the offspring, Diabetes, 34, pp. 1-7, (1985)

[9]

McEvoy RC, Franklin B, Ginsberg-Fellner F, Gestational diabetes mellitus: evidence for autoimmunity against the pancreatic Beta cells, Diabetologia, 34, pp. 507-510, (1991)

[10]

Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L, Predictive factors for development of diabetes in women with previous gestational diabetes, Am J Obstet Gynecol, 167, pp. 607-616, (1992)

← 1 2 3 →